This is the Tagline, edited under "Misc Content"

HEALTHSOUTH Reports Second Quarter Operating Earnings Per Share of $.21, Up 24%
PRNewswire
BIRMINGHAM, Ala.

HEALTHSOUTH Corporation announced operating results for the quarter and six months ended June 30, 2001. For the quarter, HEALTHSOUTH's revenues were $1.099 billion, an increase of 6% as compared to $1.036 billion for the second quarter of 2000. Adjusting in both periods for the effect of the 2001 sale of the company's occupational medicine operations, revenues for the 2001 quarter would have been up 9% over revenues for the 2000 quarter. Income before unusual and non-recurring items for the 2001 quarter was $83.1 million, an increase of 27% compared to net income of $65.2 million in the 2000 quarter. The comparable income per share (assuming dilution) was $.21 for the 2001 quarter, beating consensus Wall Street estimates and representing an increase of 24% as compared to earnings per share (assuming dilution) of $.17 in the 2000 quarter. For the quarter, the company's earnings before interest, taxes, depreciation and amortization (EBITDA) margin, excluding unusual and non- recurring items, was 28.1%, compared to 26.6% in the second quarter of 2000.

For the six months ended June 30, 2001, HEALTHSOUTH's revenues were $2.189 billion, compared to $2.058 billion for the same period in 2001. Income before unusual and non-recurring items for the 2001 period was $158.4 million, compared to net income of $130.5 million for the 2000 period. The comparable income per share (assuming dilution) for the 2001 period was $.40, compared to earnings per share (assuming dilution) of $.33 for the 2000 period.

Unusual and non-recurring items in the second quarter of 2001 totaled approximately $103 million for the quarter and six months, net of income taxes. Those items included a loss of approximately $84.3 million on the sale of the company's occupational medicine operations, an increase of approximately $6.2 million in bad debt reserves in connection with the sale of its Richmond, Virginia, medical center, approximately $8.2 million paid in settlement of a lawsuit with the U.S. Department of Justice, and approximately $4.0 million relating to the company's early termination of its $400 million secondary credit facility. The company elected to terminate its secondary credit facility because of its confidence that cash from operations and availability under its primary credit facility would provide it with ample flexibility.

"Our second quarter results demonstrate the continued successful execution of our strategic plan," said Richard M. Scrushy, Chairman of the Board and Chief Executive Officer of HEALTHSOUTH. "In a quarter full of milestones, we achieved record quarterly revenues, continued the improvement in our EBITDA margin, and saw same-store volume and pricing increases in all lines of business, while completing the planned divestitures of our occupational medicine business and our Richmond medical center. In addition, our disciplined financial policies allowed us to reduce our indebtedness by $152 million as compared to the end of the first quarter, while our accounts receivable days declined four days from the first quarter. We look forward to continuing our success in the remainder of 2001."

HEALTHSOUTH is the nation's largest provider of outpatient surgery, diagnostic imaging and rehabilitative healthcare services, with over 1,900 locations in all 50 states, the United Kingdom, Australia, Puerto Rico, and Canada. HEALTHSOUTH can be found on the Web at http://www.healthsouth.com/ .

HEALTHSOUTH will hold a conference call to discuss its third quarter results at 9:00 a.m. Central Time on Tuesday, July 31. Simultaneously with the conference call, a "webcast" of the call will be available to interested parties at http://www.healthsouth.com/ via an Internet link under the "Investor Relations" section and also at http://www.streetfusion.com/. A replay of the call will be available at the same Internet site addresses until 5:00 p.m. Central Time on August 15, 2001.

Statements contained in this press release which are not historical facts are forward-looking statements. Without limiting the generality of the preceding statement, all statements in this press release concerning or relating to estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and financial results are forward-looking statements. In addition, HEALTHSOUTH, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. Such forward-looking statements are necessarily estimates reflecting the best judgment of HEALTHSOUTH's senior management based upon current information, involve a number of risks and uncertainties and are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. HEALTHSOUTH's actual results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors, including those identified in this press release and in the public filings made by HEALTHSOUTH with the Securities and Exchange Commission, including HEALTHSOUTH's Annual Report on Form 10-K for the year ended December 31, 2000 and its Quarterly Reports on Form 10-Q, and forward- looking statements contained in this press release or in other public statements of HEALTHSOUTH or its senior management should be considered in light of those factors. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

                               HEALTHSOUTH
                        Summary Operating Results
             (unaudited; in thousands, except per share data)

                          3 Months Ended               6 Months Ended
                              June 30,                     June 30,
                         2001          2000          2001          2000

  Revenues            $1,098,989   $ 1,036,322  $ 2,189,451    $2,057,658

  Net income           $(19,947)       $65,213      $55,364      $130,539

  Weighted average
   common shares
   outstanding           388,665       385,404      388,463       385,524

  Weighted average
   common shares
   outstanding -
   assuming dilution     388,665       390,376      397,993       389,705

  Net income per
   common share          $(0.05)        $ 0.17        $0.14         $0.34

  Net income per
   common share -
   assuming dilution    $ (0.05)        $ 0.17       $ 0.14        $ 0.33

  ADJUSTMENT TO EXCLUDE
   UNUSUAL AND
  NON-RECURRING
   ITEMS IN 2001

  Net income           $(19,947)      $ 65,213      $55,364      $130,539

  Unusual and
   non-recurring
   items, net of
   minority interests    164,906           ---      164,906           ---

  Income tax benefit
   of unusual and
   non-recurring items  (61,880)           ---     (61,880)           ---

  Income excluding
   effects of unusual
   and non-recurring
   items                 $83,079       $65,213     $158,390     $ 130,539
  Weighted average
   common shares
   outstanding -
   assuming dilution     397,500       390,376      397,993       389,705
  Income per common
   share excluding
   effects of unusual
   and non-recurring
   items -
   assuming dilution       $0.21         $0.17        $0.40         $0.33

                   Additional Financial Details Follow


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income
   (UNAUDITED - In thousands, except per share amounts)


                            3 Months Ended June 30,  6 Months Ended June 30,

                                2001        2000        2001        2000

   Revenues                  $1,098,989  $1,036,322  $2,189,451  $2,057,658

   Operating unit expenses      722,705     700,462   1,458,750   1,394,454
   Corporate general and
    administrative expenses      51,214      35,706      83,868      69,727
   Provision for doubtful
    accounts                     34,858      24,256      59,241      47,512
   Depreciation and
    amortization                 93,223      90,286     184,442     179,941
   Impairment of unamortized
    loan fee costs                6,475         ---       6,475         ---
  Loss on sale of assets        139,883         ---     139,883         ---
   Interest expense              55,247      52,059     114,667     101,619
   Interest income               (1,591)     (2,102)     (4,312)     (4,936)
                              1,102,014     900,667   2,043,014   1,788,317
   Income before income
    taxes and minority
    interests                    (3,025)    135,655     146,437     269,341
   Provision for income taxes    (7,636)     42,577      41,534      85,229
   Income before minority
    interests                     4,611      93,078     104,903     184,112
   Minority interests           (24,558)    (27,865)    (49,539)    (53,573)
   Net income                  $(19,947)    $65,213     $55,364    $130,539

   Weighted average common
    shares outstanding          388,665     385,404     388,463     385,524

   Net income per common share   $(0.05)      $0.17       $0.14       $0.34

   Weighted average common
    shares outstanding -
    assuming dilution           388,665     390,376     397,993     389,705

   Net income per common
    share - assuming
    dilution:                    $(0.05)       $0.17      $0.14       $0.33

   Add-back to income for
    diluted earnings per
    share:
     Interest and
      amortization on
      convertible debt            ---         ---         ---         ---
                                   *           *           *           *


   *  The effect of these securities was antidilutive.


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income Before Unusual and Non-Recurring Items
   (UNAUDITED - In thousands, except per share amounts)


                          3 Months Ended June 30,   6 Months Ended June 30,
                             2001         2000         2001         2000

   Revenues               $1,098,989   $1,036,322   $2,189,451   $2,057,658

   Operating unit
    expenses                 722,705      700,462    1,458,750    1,394,454
   Corporate general and
    administrative
    expenses                  42,966       35,706       75,620       69,727
   Provision for doubtful
    accounts                  24,558       24,256       48,941       47,512
   Depreciation and
    amortization              93,223       90,286      184,442      179,941
   Interest expense           55,247       52,059      114,667      101,619
   Interest income            (1,591)      (2,102)      (4,312)      (4,936)
                             937,108      900,667    1,878,108    1,788,317
   Income before income
    taxes and minority
    interests                161,881      135,655      311,343      269,341
   Provision for income
    taxes                     54,244       42,577      103,414       85,229
   Income before minority
    interests                107,637       93,078      207,929      184,112
   Minority interests        (24,558)     (27,865)     (49,539)     (53,573)
   Net income                $83,079      $65,213     $158,390     $130,539

   Weighted average
    common shares
    outstanding              388,665      385,404      388,463      385,524

   Net income per common
    share                      $0.21        $0.17        $0.41        $0.34

   Weighted average
    common shares
    outstanding -
    assuming dilution        397,500      390,376      397,993      389,705

   Net income per common
    share - assuming
    dilution                   $0.21        $0.17        $0.40        $0.33

   Add-back to income for
    diluted earnings per
    share:
     Interest and
      amortization on
      convertible debt           ---          ---          ---          ---
                                  *            *            *            *


   *  The effect of these securities was antidilutive.


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income
   Three Months Ended June 30, 2001
   (UNAUDITED - In thousands, except per share amounts)

                                                                 3 Months
                                                              Ended June 30,
                                                                2001 Before
                                                Less Unusual    Unusual and
                                     3 Months     and Non-         Non-
                                   Ended June 30, Recurring      Recurring
                                        2001       Items            Items

  Revenues                           $1,098,989                  $1,098,989
  Operating unit expenses               722,705                     722,705
  Corporate general and
   administrative expenses               51,214      8,248  (1)      42,966
  Provision for doubtful accounts        34,858     10,300  (3)      24,558
  Depreciation and amortization          93,223                      93,223
  Impairment of unamortized loan fee
   costs                                  6,475      6,475  (2)         ---
  Loss on sale of assets                139,883    139,883  (3)         ---
  Interest expense                       55,247                      55,247
  Interest income                        (1,591)                     (1,591)
                                      1,102,014    164,906          937,108
  Income before income taxes and
     minority interests                  (3,025)  (164,906)         161,881
  Provision for income taxes             (7,636)   (61,880)          54,244
  Income before minority interests        4,611   (103,026)         107,637
  Minority interests                    (24,558)                    (24,558)
  Net income                           $(19,947) $(103,026)         $83,079

  Weighted average common shares
     outstanding                        388,665                     388,665

  Net income per common share            $(0.05)                      $0.21

  Weighted average common shares
     outstanding -- assuming
      dilution                          388,665                     397,500

  Net income per common share -
     assuming dilution                   $(0.05)                      $0.21

  Add-back to income for diluted
   earnings per share:
     Interest and amortization on
       convertible debt *                  ---                         ---
                                            *                           *


  * The effect of these securities was antidilutive

  (1)  Charge related to settlement agreement with the United States
       Department of Justice.
  (2)  Impairment charge related to the write-off of the unamortized balance
       of loan fees on retired debt.
  (3)  Loss and expenses related to the sale of certain facilities.


   HEALTHSOUTH Corporation and Subsidiaries
   Consolidated Statements of Income
   Six Months Ended June 30, 2001
   (UNAUDITED - In thousands, except per share amounts)


                                                                 6 Months
                                                                   Ended
                                                                  June 30,
                                                                    2001
                                                                   Before
                                                Less Unusual    Unusual and
                                     6 Months     and Non-          Non-
                                       Ended     Recurring       Recurring
                                      June 30,
                                        2001       Items           Items

  Revenues                           $2,189,451                  $2,189,451
  Operating unit expenses             1,458,750                   1,458,750
  Corporate general and
   administrative
     expenses                            83,868      8,248  (1)      75,620
  Provision for doubtful accounts        59,241     10,300  (3)      48,941
  Depreciation and amortization         184,442                     184,442
  Impairment of unamortized loan fee
   costs                                  6,475      6,475  (2)         ---
  Loss on sale of assets                139,883    139,883  (3)         ---
  Interest expense                      114,667                     114,667
  Interest income                        (4,312)                     (4,312)
                                      2,043,014    164,906        1,878,108
  Income before income taxes and
     minority interests                 146,437   (164,906)         311,343
  Provision for income taxes             41,534    (61,880)         103,414
  Income before minority interests      104,903   (103,026)         207,929
  Minority interests                    (49,539)                    (49,539)
  Net income                            $55,364  $(103,026)        $158,390

  Weighted average common shares
     outstanding                        388,463                     388,463

  Net income per common share             $0.14                       $0.41

  Weighted average common shares
     outstanding -- assuming
      dilution                          397,993                     397,993

  Net income per common share -
     assuming dilution                    $0.14                       $0.40

  Add-back to income for diluted
   earnings per share:
     Interest and amortization on
       convertible debt *                  ---                         ---
                                            *                           *


  * The effect of these securities was antidilutive


  (1)  Charge related to settlement agreement with the United States
       Department of Justice.
  (2)  Impairment charge related to the write-off of the unamortized balance
       of loan fees on retired debt.
  (3)  Loss related to the sale of certain facilities.



                         HEALTHSOUTH Corporation
                     Quarterly Statistics (Unaudited)

              1st Qtr       2nd Qtr      3rd Qtr      4th Qtr      Total

  Outpatient Division Total Visits:
  (Revised to Exclude Occupational Medicine Operations)
  1999        1,991,523    2,123,275    2,140,242    2,196,678   8,451,718
  2000        2,212,042    2,266,260    2,195,908    2,271,269   8,945,479
  2001        2,198,772    2,249,908    4,448,680

  Inpatient Division Total Patient Days:
  1999          614,686      626,262      608,878      621,349   2,471,175
  2000          647,575      643,441      668,451      650,987   2,610,454
  2001          653,434      661,635    1,315,069

  Medical Center Division Total Patient Days:
  1999           30,537       30,254       27,837       27,621     116,249
  2000           32,288       29,626       30,934       31,470     124,318
  2001           37,154       31,158       68,312

  Surgery Center Division Total Cases:
  1999          215,139      220,699      208,468      218,988     863,294
  2000          217,505      220,593      212,647      219,321     870,066
  2001          219,777      225,512      445,289

  Diagnostic Division Total Procedures:
  1999          200,496      205,909      191,493      198,728     796,626
  2000          213,505      221,052      242,647      250,621     927,825
  2001          268,645      274,623                               543,268

For more information, contact Richard M. Scrushy, Chairman & CEO, or Tadd McVay, Senior Vice President and Treasurer, at 205-967-7116

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X09797383

SOURCE: HEALTHSOUTH Corporation

Contact: Richard M. Scrushy, Chairman & CEO, or Tadd McVay, Senior Vice
President and Treasurer both of HEALTHSOUTH, +1-205-967-7116